Clinical Trial Update: Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 [Phase 2]

View source ↗

Summary

Phase 2 initial pilot study evaluating CKD-981 for safety and temporary symptom improvement in knee osteoarthritis has completed. The sponsor is Chong Kun Dang …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• CKD-981

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED